Dr. Soliman Abdel Kader Fakeeh Hospital Company (TADAWUL:4017)

Market Cap	9.41B
Revenue (ttm)	2.81B
Net Income (ttm)	287.03M
Shares Out	230.00M
EPS (ttm)	1.28
PE Ratio	32.02
Forward PE	26.69
Dividend	1.20 (2.93%)
Ex-Dividend Date	n/a

Volume	437,086
Average Volume	595,919
Open	40.90
Previous Close	40.90
Day's Range	40.80 - 41.20
52-Week Range	40.55 - 72.90
Beta	n/a
RSI	29.04
Earnings Date	Aug 14, 2025

About TADAWUL:4017

Dr. Soliman Abdel Kader Fakeeh Hospital Company, together with its subsidiaries, establishes, operates, and manages hospitals, clinics, medical, educational, and training centers in the Kingdom of Saudi Arabia. It operates through Medical Services; Education; and Trading, Retail & Others segments. The company offers various services, such as assisted reproductive therapy, audiology, bariatric surgery, pediatric, breast feeding, cardiac surgery, cardiology, chest and respiratory diseases, chiropractic medicine, dental and maxillofacial, dermatol...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1978
• Employees: 2,672
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4017

Financial Performance

In 2024, TADAWUL:4017's revenue was 2.79 billion, an increase of 19.95% compared to the previous year's 2.33 billion. Earnings were 287.55 million, an increase of 2.85%.